-
Parenteral Nutrition-associated Liver Disease
-
Jin Hong Lim
-
Surg Metab Nutr 2017;8(1):7-12. Published online June 30, 2017
-
DOI: https://doi.org/10.18858/smn.2017.8.1.7
-
-
Abstract
PDF
Parenteral nutrition-associated liver disease (PNALD) is frequently observed in patients who require long-term parenteral nutrition. PNALD is diagnosed by clinical presentation, biochemical liver function test, long-term usage of parenteral nutrition, and negative workup for other liver diseases. Pathogenesis of PNALD is multifactorial and includes prematurity, nutritional excess, sepsis, and lack of enteral nutrition. Since PNALD was first reported more than 30 years ago, there have been various attempts to find effective treatments for PNALD. Cyclic parenteral nutrition and use of ω-3 polyunsaturated long-chain fatty acids (ω-3 PUFA) instead of ω-6 PUFA were reported worldwide as effective treatments. This article reviews the literature relating to PNALD.
-
Citations
Citations to this article as recorded by 
- The Post-Discharge Caregiving Experiences of Mothers of Children with Intestinal Failure
Yunhyung Kim, Yeon Hee Kim, Jae Sim Jeong Journal of Korean Association for Qualitative Research.2024; 9(1): 1. CrossRef - Treatment Status of Parenteral Nutrition-Associated Cholestasis in Pediatric Patients at a Single Tertiary Hospital
Soh Yeon Park, Yu Jeong Son, Min Jung Geum, Jong Hee Ko, Eun Sun Son, Yun Mi Yu, Eun Joo Lee Journal of Korean Society of Health-System Pharmacists.2024; 41(4): 373. CrossRef
-
4,220
View
-
37
Download
-
2
Crossref
-
Perioperative changes in computed tomography–derived vertebral bone density and associated clinical factors in patients undergoing pancreatobiliary cancer surgery in Korea: a retrospective cohort study
-
Jinkyung Cho
, Soyoung Jeon , Woorim Jung , Yeon Su Kim , Jin Hong Lim , Hyung Sun Kim
-
Received August 3, 2026 Accepted October 29, 2026 Published online November 19, 2026
-
DOI: https://doi.org/10.15747/ACNM.26.0063
-
-
Abstract
- Purpose
This study aimed to quantify perioperative changes in computed tomography (CT)-derived vertebral bone density following pancreatobiliary cancer surgery, identify factors associated with severe postoperative bone loss, and assess the relationships of these measures with postoperative complications and survival.
Methods This single-center retrospective study included 153 patients who underwent pancreatobiliary cancer surgery between 2018 and 2020 and had evaluable preoperative and postoperative noncontrast CT scans. Vertebral bone density was expressed as the mean Hounsfield units (HU) at L1–L3, measured preoperatively and on the first postoperative outpatient CT scan; postoperative laboratory data were obtained at the same visit, 2–3 months after surgery. Logistic regression was used to examine factors associated with severe bone loss (postoperative HU <100) in patients aged ≥75 years, designated high-risk group (HRG) 6. Cox proportional hazards regression was used to assess factors associated with recurrence-free survival (RFS) and overall survival (OS).
Results The mean age was 69.6±11.4 years, and 37.9% of patients were aged ≥75 years. Mean vertebral HU decreased significantly in the overall cohort (137.6 to 130.3 HU; P=0.002), with the largest decrease among patients aged ≥ 75 years (118.7 to 107.3 HU; P=0.004). In HRG 6 (n=25), lower preoperative hemoglobin (odds ratio [OR], 0.707; 95% confidence interval [CI], 0.535–0.934) and lower postoperative albumin (OR, 0.305; 95% CI, 0.116–0.801) were associated with severe bone loss after adjustment. The 30-day complication rate was also higher in this group (24.0% vs. 8.6%). N stage, postoperative complications, and adjuvant chemotherapy were associated with RFS, whereas postoperative sodium, postoperative albumin, N stage, and tumor site were associated with OS.
Conclusion Vertebral bone density declines after pancreatobiliary cancer surgery, with the largest decrease in older patients. In this age group, severe bone loss was associated with lower preoperative hemoglobin and poorer postoperative nutritional status. These exploratory findings support monitoring nutritional status and bone health perioperatively in this population, but require prospective validation.
|